NEW YORK (GenomeWeb News) – Qiagen announced after the close of the market on Monday that Cardinal Health will make Qiagen's molecular diagnostics products available to small and mid-sized hospitals in the US not covered by Qiagen's own sales channels.

Based in Dublin, Ohio, Cardinal Health distributes pharmaceuticals and medical products to healthcare providers and has annual sales of $103 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.